The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer (English)
Free access
- New search for: Pan, Jian
- New search for: Zhao, Jinou
- New search for: Ni, Xudong
- New search for: Gan, Hualei
- New search for: Wei, Yu
- New search for: Wu, Junlong
- New search for: Zhang, Tingwei
- New search for: Wang, Qifeng
- New search for: Freedland, Stephen J.
- New search for: Wang, Beihe
- New search for: Song, Shaoli
- New search for: Ye, Dingwei
- New search for: Liu, Chang
- New search for: Zhu, Yao
- New search for: Pan, Jian
- New search for: Zhao, Jinou
- New search for: Ni, Xudong
- New search for: Gan, Hualei
- New search for: Wei, Yu
- New search for: Wu, Junlong
- New search for: Zhang, Tingwei
- New search for: Wang, Qifeng
- New search for: Freedland, Stephen J.
- New search for: Wang, Beihe
- New search for: Song, Shaoli
- New search for: Ye, Dingwei
- New search for: Liu, Chang
- New search for: Zhu, Yao
In:
Molecular Oncology
;
16
, 22
;
4011-4022
;
2022
- Article (Journal) / Electronic Resource
-
Title:The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer
-
Contributors:Pan, Jian ( author ) / Zhao, Jinou ( author ) / Ni, Xudong ( author ) / Gan, Hualei ( author ) / Wei, Yu ( author ) / Wu, Junlong ( author ) / Zhang, Tingwei ( author ) / Wang, Qifeng ( author ) / Freedland, Stephen J. ( author ) / Wang, Beihe ( author )
-
Published in:Molecular Oncology ; 16, 22 ; 4011-4022
-
Publisher:
-
Publication date:2022-12-01
-
Size:4022 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 16, Issue 22
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3909
-
Issue Information| 2022
- 3911
-
KRAS inhibitors: going noncovalentDrosten, Matthias / Barbacid, Mariano et al. | 2022
- 3916
-
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detectionFavre, Loetitia / Sako, Nouhoum / Tarfi, Sihem / Quang, Violaine Tran / Joy, Corine / Dupuy, Aurélie / Guillerm, Erell / Gaulard, Philippe / Wagner‐Ballon, Orianne / Pujals, Anaïs et al. | 2022
- 3927
-
Hyaluronic acids mediate the infiltration, migration, and M2 polarization of macrophages: evaluating metabolic molecular phenotypes in gliomasZhang, Hao / Zhang, Nan / Dai, Ziyu / Wang, Zeyu / Zhang, Xun / Liang, Xisong / Zhang, Liyang / Feng, Songshan / Wu, Wantao / Ye, Weijie et al. | 2022
- 3949
-
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironmentHariharan, Ananya / Qi, Weihong / Rehrauer, Hubert / Wu, Licun / Ronner, Manuel / Wipplinger, Martin / Kresoja‐Rakic, Jelena / Sun, Suna / Oton‐Gonzalez, Lucia / Sculco, Marika et al. | 2022
- 3975
-
Regulation of the THRA gene, encoding the thyroid hormone nuclear receptor TRα1, in intestinal lesionsGiolito, Maria Virginia / La Rosa, Théo / Farhat, Diana / Bodoirat, Serguei / Guardia, Gabriela D. A. / Domon‐Dell, Claire / Galante, Pedro A. F. / Freund, Jean‐Noel / Plateroti, Michelina et al. | 2022
- 3994
-
Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancerYoshikawa, Yuki / Stopsack, Konrad H. / Wang, Xin Victoria / Chen, Yu‐Hui / Mazzu, Ying Z. / Burton, Foster / Chakraborty, Goutam / Rajanala, Sai Harisha / Hirani, Rahim / Nandakumar, Subhiksha et al. | 2022
- 4011
-
The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancerPan, Jian / Zhao, Jinou / Ni, Xudong / Gan, Hualei / Wei, Yu / Wu, Junlong / Zhang, Tingwei / Wang, Qifeng / Freedland, Stephen J. / Wang, Beihe et al. | 2022
- 4023
-
Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysisXu, Hui / Liu, Zaoqu / Weng, Siyuan / Dang, Qin / Ge, Xiaoyong / Zhang, Yuyuan / Ren, Yuqing / Xing, Zhe / Chen, Shuang / Zhou, Yifang et al. | 2022
- 4043
-
Immune‐related gene TM4SF18 could promote the metastasis of gastric cancer cells and predict the prognosis of gastric cancer patientsQin, Xinyue / Chen, Yinhao / Ma, Shuo / Shen, Lei / Ju, Shaoqing et al. | 2022
- 4060
-
Retraction statement: Consistency analysis of microRNA‐arm expression reveals microRNA‐369‐5p/3p as tumor suppressors in gastric cancer| 2022
- 4061
-
Retraction statement: Down‐regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA‐145‐mediated inhibition of FSCN1| 2022
- 4062
-
Retraction statement: HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis| 2022
- 4063
-
Retraction statement: HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1‐IT2‐dependent manner| 2022